Merry, Eve
Thway, Khin
Jones, Robin L. http://orcid.org/0000-0003-4173-3844
Huang, Paul H. http://orcid.org/0000-0003-3972-5087
Funding for this research was provided by:
Cancer Research UK (C56167/A29363, C56167/A29363)
DH | National Institute for Health Research
Article History
Received: 2 November 2020
Accepted: 4 February 2021
First Online: 5 March 2021
Competing interests
: R.L.J.: Consulting or Advisory Role: Lilly, Immune Design, Merck Serono, Adaptimmune, Daiichi Sankyo, Eisai, Morphotek, TRACON Pharmaceuticals, Immodulon Therapeutics, Deciphera Pharmaceuticals, PharmaMar, Blueprint Medicines, Clinigen Group, Epizyme, Boehringer Ingelheim, Upto Date. The remaining authors declare no competing interests.